Timothy A. Pychyl, Ph.D. wrote an interesting post today on
Here’s a quick excerpt
Adding capecitabine, a drug that inhibits DNA synthesis and slows the growth of tumour tissue, to docetaxel, in patients with early breast cancer, leads to more toxicities and does not improve the efficacy of treatment. Category: Press …

Read the rest of this great post here

This entry was posted on Thursday, April 17th, 2008 at 1:27 am and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.